CAS 77229-68-6
:4-[(6-methoxyquinolin-8-yl)amino]pentanoic acid
- 8-(3-Carboxy-1-Methylpropylamino)-6-Methoxyquinoline
- Carboxyprimaquine
Carboxy Primaquine-d4 (Major)
CAS:Controlled ProductFormula:C15H14D4N2O3Color and Shape:NeatMolecular weight:278.34Carboxy Primaquine
CAS:Controlled ProductApplications Carboxy Primaquine, is a derivative of Primaquine (P733500), an Antimalarial agent.
References Marrs, T., et al.: Toxicol Lett., 36, 281 (1987), Karbwang, J., et al.: Clin. Pharmacokinetic., 27, 104 (1994), Noedl, H., et al.: Antimicrob. Agents Chemother., 45, 2106 (2010)Formula:C15H18N2O3Color and Shape:NeatMolecular weight:274.32Carboxy Primaquine
CAS:Carboxy Primaquine is an antimicrobial agent that inhibits the activity of cytochrome P450 enzymes. It is used to treat malaria, as it has potent anti-malarial activity against Plasmodium falciparum and Plasmodium vivax. Carboxy Primaquine is also used to treat other protozoal and bacterial infections, such as toxoplasmosis, pneumocystosis, leishmaniasis, trypanosomiasis, and leptospirosis. This drug has been shown to have immunogenic properties in vivo in humans. Inhibition of carboxyprimaquine metabolism by glucuronide conjugates has been demonstrated in liver cells from humans and rats. The pharmacokinetic profile of this drug includes a rapid absorption from the gastrointestinal tract, followed by a terminal elimination phase with a half-life of approximately 2 hours. Carboxy Primaquine is not carcinogenic in animal models
Formula:C15H18N2O3Purity:Min. 95 Area-%Color and Shape:PowderMolecular weight:274.32 g/mol



